New drug being used for the most vulnerable COVID patients

A neurologist is warning a new anti-body treatment used to fight Covid, shouldn’t be used as a substitute for vaccination.

The TGA has granted provisional approval for Sotrovimab to be used in Australians at-risk of being hospitalised with the virus.

Doctor Robin Fitzsimons has told Luke Grant, it dramatically brings down the risk of death from the disease.

Click play below to listen to the interview.